| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.2M | +0.0% |
| R&D Expense | $121.9M | -2.0% |
| SG&A Expense | $49.4M | +14.6% |
| Operating Income | -$171.3M | -27.5% |
| Interest Expense | $6.5M | +38.3% |
| Net Income | -$165.8M | -23.3% |
| EPS (Basic) | -$1.99 | +11.9% |
| EPS (Diluted) | -$1.99 | +11.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.9M | -1.4% |
| Short-term Investments | $178.1M | -16.0% |
| Current Assets | $288.2M | -12.1% |
| Total Assets | $311.0M | -13.2% |
| Current Liabilities | $32.7M | -10.0% |
| Long-term Debt | $51.0M | +0.0% |
| Total Liabilities | $85.8M | -12.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.2M | -9.4% |
| Capital Expenditures | $71K | -93.3% |
| Investing Cash Flow | $41.1M | +124.0% |
| Financing Cash Flow | $102.6M | -47.4% |
| Free Cash Flow | -$145.3M | -8.6% |
| Stockholders' Equity |
| $225.2M |
| -13.5% |